Dimerix Limited (DXB.AX)
AUD 0.32
(-5.88%)
AUD 0.32
(-5.88%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 25.64 Million AUD | 12.63% |
| 2023 | 22.76 Million AUD | 34.68% |
| 2022 | 16.9 Million AUD | 55.32% |
| 2021 | 10.88 Million AUD | 57.62% |
| 2020 | 6.9 Million AUD | 59.5% |
| 2019 | 4.32 Million AUD | 4.1% |
| 2018 | 4.15 Million AUD | 79.9% |
| 2017 | 2.31 Million AUD | 22.44% |
| 2016 | 1.88 Million AUD | 177.51% |
| 2015 | 680.31 Thousand AUD | 15.27% |
| 2014 | 590.19 Thousand AUD | 28.02% |
| 2013 | 461.01 Thousand AUD | 10.44% |
| 2012 | 417.44 Thousand AUD | -12.1% |
| 2011 | 474.88 Thousand AUD | 17.4% |
| 2010 | 404.49 Thousand AUD | -55.74% |
| 2009 | 913.85 Thousand AUD | -71.28% |
| 2008 | 3.18 Million AUD | 4.57% |
| 2007 | 3.04 Million AUD | -1.4% |
| 2006 | 3.08 Million AUD | 69.59% |
| 2005 | 1.81 Million AUD | -44.88% |
| 2004 | 3.3 Million AUD | -4.87% |
| 2003 | 3.47 Million AUD | 286.53% |
| 2002 | 898 Thousand AUD | -88.1% |
| 2001 | 7.54 Million AUD | 4898.26% |
| 2000 | 151 Thousand AUD | -86.53% |
| 1999 | 1.12 Million AUD | 59.22% |
| 1998 | 703.97 Thousand AUD | 765.92% |
| 1997 | -105.71 Thousand AUD | -20.61% |
| 1996 | -87.65 Thousand AUD | 12.35% |
| 1995 | -100 Thousand AUD | 9.09% |
| 1994 | -110 Thousand AUD | -175.0% |
| 1993 | -40 Thousand AUD | -2100.0% |
| 1992 | 2000.00 AUD | 100.36% |
| 1991 | -554 Thousand AUD | -369.49% |
| 1990 | -118 Thousand AUD | -173.29% |
| 1989 | 161 Thousand AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 25.59 Million AUD | 12.42% |
| 2024 Q4 | 18.74 Million AUD | 0.0% |
| 2024 Q2 | 6.89 Million AUD | 0.0% |
| 2023 FY | 22.76 Million AUD | 34.68% |
| 2023 Q2 | 9.68 Million AUD | 0.0% |
| 2023 Q4 | 13.13 Million AUD | 0.0% |
| 2022 Q4 | 4.31 Million AUD | 0.0% |
| 2022 Q2 | 6.61 Million AUD | 0.0% |
| 2022 FY | 16.9 Million AUD | 55.32% |
| 2021 Q4 | 6.52 Million AUD | 0.0% |
| 2021 FY | 10.88 Million AUD | 57.62% |
| 2021 Q2 | 4.38 Million AUD | 0.0% |
| 2020 Q2 | 3.24 Million AUD | 0.0% |
| 2020 FY | 6.9 Million AUD | 59.5% |
| 2020 Q4 | 3.67 Million AUD | 0.0% |
| 2019 Q2 | 2.02 Million AUD | 0.0% |
| 2019 FY | 4.32 Million AUD | 4.1% |
| 2019 Q4 | 2.31 Million AUD | 0.0% |
| 2018 FY | 4.15 Million AUD | 79.9% |
| 2018 Q4 | 2.29 Million AUD | 0.0% |
| 2018 Q2 | 1.86 Million AUD | 0.0% |
| 2017 Q2 | 1.12 Million AUD | 0.0% |
| 2017 Q4 | 1.18 Million AUD | 0.0% |
| 2017 FY | 2.31 Million AUD | 22.44% |
| 2016 Q4 | 1.06 Million AUD | 0.0% |
| 2016 FY | 1.88 Million AUD | 177.51% |
| 2016 Q2 | 4.79 Million AUD | 0.0% |
| 2015 FY | 680.31 Thousand AUD | 15.27% |
| 2015 Q1 | 63.22 Thousand AUD | 0.0% |
| 2015 Q2 | 418.87 Thousand AUD | 562.49% |
| 2015 Q3 | 61.68 Thousand AUD | -85.27% |
| 2015 Q4 | 344.25 Thousand AUD | 458.06% |
| 2014 Q4 | - AUD | -100.0% |
| 2014 FY | 590.19 Thousand AUD | 28.02% |
| 2014 Q3 | 63.22 Thousand AUD | 0.0% |
| 2014 Q2 | 63.22 Thousand AUD | -39.8% |
| 2014 Q1 | 105.03 Thousand AUD | 0.0% |
| 2013 FY | 461.01 Thousand AUD | 10.44% |
| 2013 Q4 | - AUD | -100.0% |
| 2013 Q3 | 105.03 Thousand AUD | 0.0% |
| 2013 Q1 | 101.09 Thousand AUD | 0.0% |
| 2013 Q2 | 105.03 Thousand AUD | 3.9% |
| 2012 FY | 417.44 Thousand AUD | -12.1% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q3 | 101.09 Thousand AUD | 0.0% |
| 2012 Q2 | 101.09 Thousand AUD | -5.47% |
| 2012 Q1 | 106.93 Thousand AUD | 0.0% |
| 2011 Q3 | 106.93 Thousand AUD | 0.0% |
| 2011 Q2 | 106.93 Thousand AUD | 31.69% |
| 2011 FY | 474.88 Thousand AUD | 17.4% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q1 | 81.2 Thousand AUD | 0.0% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 FY | 404.49 Thousand AUD | -55.74% |
| 2010 Q3 | 81.2 Thousand AUD | 0.0% |
| 2010 Q2 | 81.2 Thousand AUD | -8.43% |
| 2010 Q1 | 88.67 Thousand AUD | 0.0% |
| 2009 Q1 | 216.28 Thousand AUD | 0.0% |
| 2009 Q2 | 88.67 Thousand AUD | -59.0% |
| 2009 FY | 913.85 Thousand AUD | -71.28% |
| 2009 Q3 | 88.67 Thousand AUD | 0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2008 Q1 | 78.92 Thousand AUD | 0.0% |
| 2008 Q2 | 216.28 Thousand AUD | 174.04% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 FY | 3.18 Million AUD | 4.57% |
| 2008 Q3 | 216.28 Thousand AUD | 0.0% |
| 2007 Q1 | 446.44 Thousand AUD | 0.0% |
| 2007 Q2 | 78.92 Thousand AUD | -82.32% |
| 2007 Q3 | 78.92 Thousand AUD | 0.0% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 3.04 Million AUD | -1.4% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q2 | 446.44 Thousand AUD | 69.72% |
| 2006 Q3 | 446.44 Thousand AUD | 0.0% |
| 2006 Q1 | 263.04 Thousand AUD | 0.0% |
| 2006 FY | 3.08 Million AUD | 69.59% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 263.04 Thousand AUD | 0.0% |
| 2005 Q2 | 263.04 Thousand AUD | -10.21% |
| 2005 FY | 1.81 Million AUD | -44.88% |
| 2005 Q1 | 292.95 Thousand AUD | 0.0% |
| 2004 FY | 3.3 Million AUD | -4.87% |
| 2004 Q3 | 292.95 Thousand AUD | 0.0% |
| 2004 Q2 | 292.95 Thousand AUD | -4.65% |
| 2004 Q1 | 307.25 Thousand AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2003 Q3 | 307.25 Thousand AUD | 0.0% |
| 2003 Q1 | 160.6 Thousand AUD | 0.0% |
| 2003 FY | 3.47 Million AUD | 286.53% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q2 | 307.25 Thousand AUD | 91.31% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 FY | 898 Thousand AUD | -88.1% |
| 2002 Q1 | 1.54 Million AUD | 0.0% |
| 2002 Q2 | 160.6 Thousand AUD | -89.6% |
| 2002 Q3 | 160.6 Thousand AUD | 0.0% |
| 2001 FY | 7.54 Million AUD | 4898.26% |
| 2001 Q1 | -200.41 Thousand AUD | 0.0% |
| 2001 Q2 | 1.54 Million AUD | 870.73% |
| 2001 Q3 | 1.54 Million AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2000 FY | 151 Thousand AUD | -86.53% |
| 2000 Q4 | - AUD | 100.0% |
| 2000 Q3 | -200.41 Thousand AUD | 0.0% |
| 2000 Q1 | 441.79 Thousand AUD | 0.0% |
| 2000 Q2 | -200.41 Thousand AUD | -145.36% |
| 1999 Q2 | 441.79 Thousand AUD | 35.71% |
| 1999 FY | 1.12 Million AUD | 59.22% |
| 1999 Q4 | - AUD | -100.0% |
| 1999 Q3 | 441.79 Thousand AUD | 0.0% |
| 1999 Q1 | 325.53 Thousand AUD | 0.0% |
| 1998 Q4 | 325.53 Thousand AUD | 0.0% |
| 1998 Q3 | 325.53 Thousand AUD | 0.0% |
| 1998 Q2 | 325.53 Thousand AUD | 628.8% |
| 1998 FY | 703.97 Thousand AUD | 765.92% |
| 1998 Q1 | -61.56 Thousand AUD | 0.0% |
| 1997 Q3 | -61.56 Thousand AUD | 0.0% |
| 1997 Q1 | -52.78 Thousand AUD | 0.0% |
| 1997 Q4 | - AUD | 100.0% |
| 1997 FY | -105.71 Thousand AUD | -20.61% |
| 1997 Q2 | -61.56 Thousand AUD | -16.62% |
| 1996 Q3 | -52.78 Thousand AUD | 0.0% |
| 1996 Q1 | -55.75 Thousand AUD | 0.0% |
| 1996 Q4 | -52.78 Thousand AUD | 0.0% |
| 1996 FY | -87.65 Thousand AUD | 12.35% |
| 1996 Q2 | -52.78 Thousand AUD | 5.31% |
| 1995 Q3 | -55.75 Thousand AUD | 0.0% |
| 1995 Q4 | -55.75 Thousand AUD | 0.0% |
| 1995 Q2 | -55.75 Thousand AUD | 9.72% |
| 1995 Q1 | -61.75 Thousand AUD | 0.0% |
| 1995 FY | -100 Thousand AUD | 9.09% |
| 1994 Q2 | -61.75 Thousand AUD | -135.24% |
| 1994 Q1 | -26.25 Thousand AUD | 0.0% |
| 1994 Q4 | -61.75 Thousand AUD | 0.0% |
| 1994 FY | -110 Thousand AUD | -175.0% |
| 1994 Q3 | -61.75 Thousand AUD | 0.0% |
| 1993 Q2 | -26.25 Thousand AUD | -10600.0% |
| 1993 Q4 | -26.25 Thousand AUD | 0.0% |
| 1993 FY | -40 Thousand AUD | -2100.0% |
| 1993 Q3 | -26.25 Thousand AUD | 0.0% |
| 1993 Q1 | 250.00 AUD | 0.0% |
| 1992 FY | 2000.00 AUD | 100.36% |
| 1992 Q1 | -224.5 Thousand AUD | 0.0% |
| 1992 Q2 | 250.00 AUD | 100.11% |
| 1992 Q4 | 250.00 AUD | 0.0% |
| 1992 Q3 | 250.00 AUD | 0.0% |
| 1991 Q3 | -224.5 Thousand AUD | 0.0% |
| 1991 Q4 | -224.5 Thousand AUD | 0.0% |
| 1991 Q1 | -59.25 Thousand AUD | 0.0% |
| 1991 Q2 | -224.5 Thousand AUD | -278.9% |
| 1991 FY | -554 Thousand AUD | -369.49% |
| 1990 Q2 | -59.25 Thousand AUD | -194.42% |
| 1990 Q3 | -59.25 Thousand AUD | 0.0% |
| 1990 Q4 | -59.25 Thousand AUD | 0.0% |
| 1990 FY | -118 Thousand AUD | -173.29% |
| 1990 Q1 | 62.75 Thousand AUD | 0.0% |
| 1989 Q2 | 62.75 Thousand AUD | 0.0% |
| 1989 FY | 161 Thousand AUD | 0.0% |
| 1989 Q3 | 62.75 Thousand AUD | 0.0% |
| 1989 Q4 | 62.75 Thousand AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 39.57 Million AUD | 35.202% |
| Anatara Lifesciences Ltd | 710.21 Thousand AUD | -3510.624% |
| Zelira Therapeutics Limited | 5.94 Million AUD | -331.087% |
| Biome Australia Limited | 7.91 Million AUD | -224.138% |
| Patrys Limited | 4.93 Million AUD | -419.798% |
| Orthocell Limited | 15.36 Million AUD | -66.845% |
| Imugene Limited | 135.09 Million AUD | 81.018% |
| Noxopharm Limited | 7 Million AUD | -266.322% |
| PYC Therapeutics Limited | 60.91 Million AUD | 57.904% |
| Chimeric Therapeutics Limited | 19.76 Million AUD | -29.725% |
| Prescient Therapeutics Limited | 10.89 Million AUD | -135.286% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -2774.345% |
| Cynata Therapeutics Limited | 11.12 Million AUD | -130.531% |
| CSL Limited | 7.56 Billion AUD | 99.661% |
| Arovella Therapeutics Limited | 10.78 Million AUD | -137.762% |
| Bio-Gene Technology Limited | 2.76 Million AUD | -828.763% |
| Clinuvel Pharmaceuticals Limited | 31.29 Million AUD | 18.065% |
| Starpharma Holdings Limited | 22.81 Million AUD | -12.392% |
| Nanollose Limited | 12.5 Thousand AUD | -205029.71% |
| Memphasys Limited | 3.67 Million AUD | -597.134% |
| Invex Therapeutics Ltd | 3.34 Million AUD | -666.412% |
| NeuroScientific Biopharmaceuticals Limited | 1.96 Million AUD | -1204.854% |
| Amplia Therapeutics Limited | 8.43 Million AUD | -203.984% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -4160.953% |
| Island Pharmaceuticals Limited | 4.12 Million AUD | -521.601% |
| Race Oncology Limited | 14.77 Million AUD | -73.612% |
| Nyrada Inc. | 4.55 Million AUD | -462.949% |
| Telix Pharmaceuticals Limited | 269.26 Million AUD | 90.477% |
| PharmAust Limited | 6.65 Million AUD | -285.208% |
| Immutep Limited | 42.87 Million AUD | 40.191% |
| Clarity Pharmaceuticals Ltd | 56.3 Million AUD | 54.458% |
| Alterity Therapeutics Limited | 23.4 Million AUD | -9.555% |
| BTC Health Limited | -1.03 Million AUD | 2568.245% |
| Acrux Limited | 8.55 Million AUD | -199.921% |
| Neuren Pharmaceuticals Limited | 32.69 Million AUD | 21.573% |
| Biotron Limited | 5.11 Million AUD | -401.759% |
| Tissue Repair Ltd | 6.66 Million AUD | -284.641% |
| AdAlta Limited | 6.76 Million AUD | -278.805% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -8469.808% |
| Hexima Limited | 1 Million AUD | -2442.083% |
| AnteoTech Limited | 12.18 Million AUD | -110.415% |
| Paradigm Biopharmaceuticals Limited | 65.1 Million AUD | 60.611% |
| Recce Pharmaceuticals Ltd | 21.68 Million AUD | -18.256% |
| Avecho Biotechnology Limited | 4.54 Million AUD | -464.159% |
| Actinogen Medical Limited | 22.77 Million AUD | -12.616% |
| Immuron Limited | 9.13 Million AUD | -180.625% |
| Argenica Therapeutics Limited | 8.26 Million AUD | -210.108% |